Citation: P. Markaki et E. Melissari, OCCURRENCE OF AFLATOXIN M-1 IN COMMERCIAL PASTEURIZED MILK DETERMINEDWITH ELISA AND HPLC, Food additives and contaminants, 14(5), 1997, pp. 451-456
Authors:
DAS SK
COHEN AT
EDMONDSON RA
MELISSARI E
KAKKAR VV
Citation: Sk. Das et al., LOW-MOLECULAR-WEIGHT HEPARIN VERSUS WARFARIN FOR PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM - A RANDOMIZED TRIAL, World journal of surgery, 20(5), 1996, pp. 521-527
Authors:
MURRAY WJG
LINDO VS
KAKKAR VV
MELISSARI E
Citation: Wjg. Murray et al., LONG-TERM ADMINISTRATION OF HEPARIN AND HEPARIN FRACTIONS AND OSTEOPOROSIS IN EXPERIMENTAL-ANIMALS, Blood coagulation & fibrinolysis, 6(2), 1995, pp. 113-118
Authors:
DAS SK
MELISSARI E
SEMBHI K
VAIDYANATHAN I
KAKKAR VV
Citation: Sk. Das et al., SIGNIFICANCE OF D-DIMMERS, F1, F2 FRAGMENTS AND TAT IN DIAGNOSIS AND MANAGEMENT OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 73(6), 1995, pp. 958-958
Citation: I. Vaidyanathan et al., CLINICAL-SIGNIFICANCE OF HEPARIN COFACTOR-II (HCII) IN PATIENTS TREATED WITH PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), Thrombosis and haemostasis, 73(6), 1995, pp. 1043-1043
Authors:
ANDERSON S
COHEN AT
MELISSARI E
SCULLY MS
KAKKAR VV
Citation: S. Anderson et al., LOSS OF HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS UNDERGOING PTCA, Thrombosis and haemostasis, 73(2), 1995, pp. 328-329
Authors:
LINDO VS
KAKKAR VV
LEARMONTH M
MELISSARI E
ZAPPACOSTA F
PANICO M
MORRIS HR
Citation: Vs. Lindo et al., ANTITHROMBIN-TRI (ALA382 TO THR) CAUSING SEVERE THROMBOEMBOLIC TENDENCY UNDERGOES THE S-TO-R TRANSITION AND IS ASSOCIATED WITH A PLASMA-INACTIVE HIGH-MOLECULAR-WEIGHT COMPLEX OF AGGREGATED ANTITHROMBIN, British Journal of Haematology, 89(3), 1995, pp. 589-601
Citation: Vs. Lindo et al., CLEAVED ANTITHROMBIN (ATC) - A NEW MARKER FOR THROMBIN GENERATION ANDACTIVATION OF THE COAGULATION SYSTEM, British Journal of Haematology, 89(1), 1995, pp. 157-162
Authors:
MILLAR DS
WACEY AI
RIBANDO J
MELISSARI E
LAURSEN B
WOODS P
KAKKAR VV
COOPER DN
Citation: Ds. Millar et al., 3 NOVEL MISSENSE MUTATIONS IN THE ANTITHROMBIN-III (AT3) GENE CAUSINGRECURRENT VENOUS THROMBOSIS, Human genetics, 94(5), 1994, pp. 509-512
Authors:
COHEN AT
PHILLIPS MJ
EDMONDSON RA
SKINNER JA
DAS SK
COOPER DJ
THOMAS EM
MELISSARI E
KAKKAR VV
Citation: At. Cohen et al., A DOSE-RANGING STUDY TO EVALUATE DERMATAN SULFATE IN PREVENTING DEEP-VEIN THROMBOSIS FOLLOWING TOTAL HIP-ARTHROPLASTY, Thrombosis and haemostasis, 72(6), 1994, pp. 793-798
Citation: Kd. Pemberton et al., THE INFLUENCE OF TAMOXIFEN IN-VIVO ON THE MAIN NATURAL ANTICOAGULANTSAND FIBRINOLYSIS, Blood coagulation & fibrinolysis, 4(6), 1993, pp. 935-942
Authors:
COHEN AT
PHILLIPS MJ
EDMONDSON RA
MELISSARI E
VAIDYANATHAN I
KAKKAR VV
Citation: At. Cohen et al., DERMATAN SULFATE FOR PROPHYLAXIS OF DEEP-VEIN THROMBOSIS (DVT) IN ELECTIVE HIP-SURGERY - A DOSE-FINDING TRIAL, Thrombosis and haemostasis, 69(6), 1993, pp. 621-621
Authors:
MELISSARI E
MURRAY WJG
DAS S
WILSON NV
PHILIP M
KAKKAR VV
Citation: E. Melissari et al., DOES LOW-MOLECULAR-WEIGHT HEPARIN HAVE A ROLE IN THE DEVELOPMENT OF OSTEOPOROSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 646-646
Authors:
MELISSARI E
DAWSON G
LINDO VS
PEMBERTON KD
CORRIGAN N
VAIDYANATHAN I
KAKKAR VV
SMYTH DN
JEWITT DE
Citation: E. Melissari et al., ALTERATIONS IN HEMOSTATIC PARAMETERS IN PREDICTING RESTENOSIS FOLLOWING A PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTCA), Thrombosis and haemostasis, 69(6), 1993, pp. 812-812
Citation: I. Vaidyanathan et al., IS HEPARIN COFACTOR-II (HCII) ESTIMATION RELEVANT TO THE INVESTIGATION OF THROMBOPHILIA OF UNKNOWN ETIOLOGY, Thrombosis and haemostasis, 69(6), 1993, pp. 900-900
Authors:
LINDO V
MELISSARI E
MILLAR DS
COOPER DN
LEARMONTH M
KAKKAR VV
Citation: V. Lindo et al., INHERITED FUNCTIONAL ANTITHROMBIN-III (ATIII) VARIANT WITH FLUCTUATING FUNCTIONAL-ACTIVITY, Thrombosis and haemostasis, 69(6), 1993, pp. 1255-1255
Authors:
WEITZEL D
PHILLIPS MJ
EDMONDSON RA
COHEN AT
MELISSARI E
SANDERSON RM
WOLF H
KAKKAR VV
Citation: D. Weitzel et al., AN EVALUATION OF THE EFFECTS OF A SINGLE-DOSE OF PROSTAGLANDIN-E(1) ON FIBRINOLYTIC-ACTIVITY DURING MAJOR SURGERY, Thrombosis and haemostasis, 69(6), 1993, pp. 1265-1265
Authors:
EDMONDSON RA
COHEN AT
PHILLIPS MJ
MELISSARI E
VAIDYANATHAN I
KAKKAR VV
Citation: Ra. Edmondson et al., THROMBIN INHIBITOR (HIRULOG(TM)) IN THE TREATMENT OF CALF VEIN-THROMBOSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 1301-1301
Authors:
GOODWIN CA
MELISSARI E
KAKKAR VV
SCULLY MF
Citation: Ca. Goodwin et al., PLASMA-LEVELS OF TISSUE FACTOR PATHWAY INHIBITOR IN THROMBOPHILIC PATIENTS, Thrombosis research, 72(4), 1993, pp. 363-366